Sentence examples for trials for determining from inspiring English sources
Most clinical experience has been gained with the radioactive tracers 99 mTc-Annexin V [10, 11] and 99 mTc-6-hydrazinonicotinic [HYNIC]-radiolabeled Annexin V, the latter being used in phase II/III trials for determining the efficacy of chemotherapy in cancer patients [1].
The CIPNM sum score should be further validated in future trials for determining the specificity and sensitivity of CIPNM in critically ill patients.
Although the results of long-term, randomized, placebo-controlled trials for determining the cardiovascular effects of mitiglinide on clinical outcomes are awaited, this review is aimed at summarizing substantial insights into this topic.
Because noncarcinoid appendiceal neoplasms are rare and the number of high-volume peritoneal-surface oncology centers limited, CRS-HIPEC clinical trials for determining the best dose of IP MMC are unlikely.
Although the results of long-term, randomized, placebo-controlled trials for determining cardiovascular effects of antidiabetic agents in terms of clinical outcomes are awaited, herein, we aimed to summarize substantial insights about mitiglinide.
A systematic review of the literature was undertaken to identify all prospective randomized trials for determining whether the overall clinical results (as a function of durability, function, and adverse events) favored HA-coated tibial components.
Further, there is no indication that appellant either presented evidence on this question at trial or urged any standard at trial for determining that issue.
The prospective, randomized, placebo-controlled trial for determining the efficacy of statins in CI-AKI prevention was performed by Jo et al. [ 74] in 2008.
It could serve as a trial measure for determining popular acceptance of the idea of a halt to testing, and as a prelude to a treaty.
We studied the 6 m FFTF as recently proposed by Martin and colleagues as a potential clinical trial endpoint for determining aGVHD treatment success.
It is also important to note that the relatively short period of follow-up, along with the relative lack of power inherent in these clinical trial data for determining treatment group differences in rare safety events, limit our ability to draw definitive conclusions from these analyses.
